Discontinuation of smokeless tobacco and mortality risk after myocardial infarction

Circulation

Volumn 130, Issue 4, 2014, Pages 325-332

  Arefalk, Gabriel ^a   Hambraeus, Kristina ^c   Lind, Lars ^a   Michaëlsson, Karl ^b   Lindahl, Bertil ^a   Sundström, Johan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c FALUN HOSPITAL   (Sweden)

Author keywords

mortality; myocardial infarction; prognosis; risk factors; smokeless tobacco

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY CARE UNIT; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; SWEDEN;

MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SMOKELESS TOBACCO;

AGED; CORONARY CARE UNITS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK; SMOKING; SMOKING CESSATION; SWEDEN; TOBACCO USE CESSATION; TOBACCO, SMOKELESS;

EID: 84904739957     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.007252     Document Type: Article

References (30)

1. Market for snus and moist snuff. Swedish Match Web site. http:// www.swedishmatch.com/en/Our-business/Snus-and-snuff/Marketdevelopment/. Accessed October 21, 2013.
2. Living Conditions. Tobacco habits, 2010-2011. Statistics Sweden Web Site. http://www.scb.se. Accessed October 21, 2013.
3. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008;10:1773-1782.
4. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-97.
5. Rohani M, Agewall S. Oral snuff impairs endothelial function in healthy snuff users. J Intern Med. 2004;255:379-383.
6. Granberry MC, Smith ES 3rd, Troillett RD, Eidt JF. Forearm endothelial response in smokeless tobacco users compared with cigarette smokers and nonusers of tobacco. Pharmacotherapy. 2003;23:974-978.
7. Hirsch JM, Hedner J, Wernstedt L, Lundberg J, Hedner T. Hemodynamic effects of the use of oral snuff. Clin Pharmacol Ther. 1992;52:394-401.
8. Wolk R, Shamsuzzaman AS, Svatikova A, Huyber CM, Huck C, Narkiewicz K, Somers VK. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men. J Am Coll Cardiol. 2005;45:910-914.
9. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology. 2005;16:12-16.
10. Janzon E, Hedblad B. Swedish snuff and incidence of cardiovascular disease: a population-based cohort study. BMC Cardiovasc Disord. 2009;9:21.
11. Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, Hallqvist J, Magnusson C. Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry. J Intern Med. 2009;265:717-724.
12. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ. 1992;305:1252-1256.
13. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a populationbased study in middle-aged men. J Am Coll Cardiol. 1999;34:1784-1790.
14. Haglund B, Eliasson M, Stenbeck M, Rosén M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health. 2007;35:618-622.
15. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262:351-359.
16. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262:360-367.
17. Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ. 2009;339:b3060.
18. Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Hallqvist J, Hedblad B, Jansson JH, Nilsson P, Pedersen N, Trolle Lagerros Y, Ostergren PO, Magnusson C. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012;27:771-779.
19. Yashima M, Ohara T, Cao JM, Kim YH, Fishbein MC, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction. Am J Physiol Heart Circ Physiol. 2000;278:H2124-H2133.
20. Ohara T, Yashima M, Hamzei A, Favelyukis M, Park A, Kim YH, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine increases spatiotemporal complexity of ventricular fibrillation wavefront on the epicardial border zone of healed canine infarcts. J Cardiovasc Pharmacol Ther. 1999;4:121-127.
21. Villarreal FJ, Hong D, Omens J. Nicotine-modified postinfarction left ventricular remodeling. Am J Physiol. 1999;276(pt 2):H1103-H1106.
22. Arefalk G, Hergens MP, Ingelsson E, Arnlöv J, Michaëlsson K, Lind L, Ye W, Nyrén O, Lambe M, Sundström J. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol. 2012;19:1120-1127.
23. Stenestrand U, Wallentin L; Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430-436.
24. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010;33:S11-S61.
25. Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol. 2008;8:70.
26. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S; INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647-658.
27. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84:399-404.
28. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther. 1997;2:291-298.
29. Bellet S, DeGuzman NT, Kostis JB, Roman L, Fleischmann D. The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J. 1972;83:67-76.
30. Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, Chellappan S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 2009;4:e7524.